Oesophageal Carcinoma Withdrawn Phase 2 Trials for Cetuximab (DB00002)

Also known as: Carcinoma of Esophagus / Esophageal Carcinoma / Carcinoma, Esophageal / Esophagus Carcinoma / Carcinoma of oesophagus NOS / Carcinoma of oesophagus / Oesophageal carcinoma NOS / Esophageal carcinoma NOS

IndicationStatusPhase
DBCOND0032513 (Oesophageal Carcinoma)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00636298Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First TherapyTreatment